This piece is about monoclonal antibodies & there use in preventing HIV. I've blogged about these antibodies before, but as a treatment, not a form of PrEP. At this point, the approach only works if the antibody & viral strain match. Currently, 70% of the time, they didn't. Even if they do, the prevention rate is only 75%.
This may be ready for wide application, but the research is important. It may add to HIV research or other viruses, such as COVID-19. Research often provides unexpected outcomes & applications. Give this a read.
Cya...
No comments:
Post a Comment